|
|
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.
About 100 new prescription or over-the-counter drugs come into the U.S. market every year.
More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.
Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.